Findings

What do systematic reviews say?

1,230 questions · 1,303 findings · 326 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 73 · 5.6%GRADE not reported 21 · 1.6%Very low 497 · 38.1%Low 403 · 30.9%Moderate 245 · 18.8%High 64 · 4.9%

Adults: higher dose/longer course vs lower dose/shorter course

FEV1 % predicted · Adults with acute asthma

1 finding from 1 review

Different oral corticosteroid regimens for acute asthma 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 41 participants
Very low

Adults: higher dose/longer course vs lower dose/shorter course

All adverse events · Adults with acute asthma

It is very uncertain whether adults: higher dose/longer course changes all adverse events compared with lower dose/shorter course (very low certainty).

1 finding from 1 review

Different oral corticosteroid regimens for acute asthma 2016 · Cochrane Headline outcomes only
OR 4.15 [0.94, 18.41]
1 study · 43 participants
Very low

Anticipated low‐responders: higher vs lower dose of FSH

300/450 IU vs 150 IU · women undergoing IVF/ICSI who are anticipated to have a low‐response to stimulation based on one or more ORT measure

Anticipated low responders: higher showed no clear difference in 300/450 IU vs 150 IU compared with lower dose of FSH (low certainty).

1 finding from 1 review

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro… 2024 · Cochrane Headline outcomes only
OR 1.2 [0.78, 1.86]
3 studies · 538 participants
Low

Anticipated low‐responders: higher vs lower dose of FSH

400/450 IU vs 300 IU · women undergoing IVF/ICSI who are anticipated to have a low‐response to stimulation based on one or more ORT measure

Anticipated low responders: higher showed no clear difference in 400/450 IU vs 300 IU compared with lower dose of FSH (low certainty).

1 finding from 1 review

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro… 2024 · Cochrane Headline outcomes only
OR 0.77 [0.19, 3.19]
1 study · 62 participants
Low

Anticipated low‐responders: higher vs lower dose of FSH

IU vs 450 IU · women undergoing IVF/ICSI who are anticipated to have a low‐response to stimulation based on one or more ORT measure

Anticipated low responders: higher showed no clear difference in IU vs 450 IU compared with lower dose of FSH (low certainty).

1 finding from 1 review

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro… 2024 · Cochrane Headline outcomes only
OR 1.33 [0.71, 2.52]
1 study · 356 participants
Low

Anticipated high responders: higher vs lower dose of FSH

IU vs 100 IU · women undergoing IVF/ICSI who are anticipated to have a hyper‐response to stimulation based on at least one ORT measure

Anticipated high responders: higher showed no clear difference in IU vs 100 IU compared with lower dose of FSH (low certainty).

1 finding from 1 review

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro… 2024 · Cochrane Headline outcomes only
OR 0.98 [0.66, 1.46]
1 study · 521 participants
Low

Children: higher dose/longer course vs lower dose/shorter course

Re‐admission during · children with acute asthma

1 finding from 1 review

Different oral corticosteroid regimens for acute asthma 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 98 participants
Very low

Children: higher dose/longer course vs lower dose/shorter course

Asthma symptoms · children with acute asthma

Children: higher dose/longer course showed no clear difference in asthma symptoms Symptom free by 7 days compared with lower dose/shorter course (moderate certainty).

1 finding from 1 review

Different oral corticosteroid regimens for acute asthma 2016 · Cochrane Headline outcomes only
OR 1.22 [0.67, 2.19]
1 study · 201 participants
Moderate

Children: higher dose/longer course vs lower dose/shorter course

Serious adverse events · children with acute asthma

1 finding from 1 review

Different oral corticosteroid regimens for acute asthma 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 201 participants
GRADE not reported

Children: higher dose/longer course vs lower dose/shorter course

Exacerbations · children with acute asthma

Children: higher dose/longer course showed no clear difference in new exacerbation during compared with lower dose/shorter course (low certainty).

2 findings from 1 review

Different oral corticosteroid regimens for acute asthma 2016 · Cochrane Headline outcomes only
OR 1.38 [0.25, 7.47]
2 studies · 231 participants
Low
Different oral corticosteroid regimens for acute asthma 2016 · Cochrane Headline outcomes only
OR 2.17 [0.67, 7.01]
1 study · 100 participants
Very low

Children: higher dose/longer course vs lower dose/shorter course

FEV1 % predicted · children with acute asthma

1 finding from 1 review

Different oral corticosteroid regimens for acute asthma 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
GRADE not reported

Children: higher dose/longer course vs lower dose/shorter course

All adverse events · children with acute asthma

Children: higher dose/longer course showed no clear difference in all adverse events compared with lower dose/shorter course (moderate certainty).

1 finding from 1 review

Different oral corticosteroid regimens for acute asthma 2016 · Cochrane Headline outcomes only
OR 0.67 [0.11, 4.08]
1 study · 201 participants
Moderate

A dose of vitamin D 601 IU or higher vs 600 IU or lower alone or with other nutrients

Pre‐eclampsia · women during pregnancy

A dose of vitamin D 601 IU or higher showed no clear difference in pre‐eclampsia compared with 600 IU or lower alone or with other nutrients (low certainty).

1 finding from 1 review

Regimens of vitamin D supplementation for women during pregnancy 2019 · Cochrane Headline outcomes only
RR 0.96 [0.65, 1.42]
5 studies · 1553 participants
Low

A dose of vitamin D 601 IU or higher vs 600 IU or lower alone or with other nutrients

Gestational diabetes · women during pregnancy

A dose of vitamin D 601 IU or higher probably leads to lower gestational diabetes compared with 600 IU or lower alone or with other nutrients (moderate certainty).

1 finding from 1 review

Regimens of vitamin D supplementation for women during pregnancy 2019 · Cochrane Headline outcomes only
RR 0.54 [0.34, 0.86]
5 studies · 1846 participants
Moderate

A dose of vitamin D 601 IU or higher vs 600 IU or lower alone or with other nutrients

Preterm birth · women during pregnancy

A dose of vitamin D 601 IU or higher showed no clear difference in preterm birth compared with 600 IU or lower alone or with other nutrients (low certainty).

1 finding from 1 review

Regimens of vitamin D supplementation for women during pregnancy 2019 · Cochrane Headline outcomes only
RR 1.25 [0.92, 1.69]
4 studies · 2294 participants
Low

A dose of vitamin D 601 IU or higher vs 600 IU or lower alone or with other nutrients

Low birthweight · women during pregnancy

It is very uncertain whether A dose of vitamin D 601 IU or higher changes low birthweight compared with 600 IU or lower alone or with other nutrients (very low certainty).

1 finding from 1 review

Regimens of vitamin D supplementation for women during pregnancy 2019 · Cochrane Headline outcomes only
RR 0.9 [0.66, 1.24]
4 studies · 1550 participants
Very low

Anticipated normal responders: higher vs lower dose of FSH

IU vs 150 IU · women undergoing IVF/ICSI who are anticipated to have a normal response to stimulation based on at least one ORT measure

1 finding from 1 review

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro… 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 37 participants
GRADE not reported

Anticipated normal responders: higher vs lower dose of FSH

IU vs 100 IU · women undergoing IVF/ICSI who are anticipated to have a normal response to stimulation based on at least one ORT measure

Anticipated normal responders: higher showed no clear difference in IU vs 100 IU compared with lower dose of FSH (low certainty).

1 finding from 1 review

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro… 2024 · Cochrane Headline outcomes only
OR 0.88 [0.57, 1.36]
2 studies · 522 participants
Low

Anticipated normal responders: higher vs lower dose of FSH

225/200 IU vs 150 IU · women undergoing IVF/ICSI who are anticipated to have a normal response to stimulation based on at least one ORT measure

Anticipated normal responders: higher showed no clear difference in 225/200 IU vs 150 IU compared with lower dose of FSH (low certainty).

1 finding from 1 review

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro… 2024 · Cochrane Headline outcomes only
OR 0.98 [0.7, 1.36]
2 studies · 686 participants
Low

Anticipated normal responders: higher vs lower dose of FSH

IU vs 225 IU · women undergoing IVF/ICSI who are anticipated to have a normal response to stimulation based on at least one ORT measure

Anticipated normal responders: higher showed no clear difference in IU vs 225 IU compared with lower dose of FSH (low certainty).

1 finding from 1 review

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro… 2024 · Cochrane Headline outcomes only
OR 0.65 [0.32, 1.32]
1 study · 135 participants
Low